We are Mammotome, a global team committed to developing and distributing breakthrough technologies in breast cancer care. We boast a comprehensive range of products that create better outcomes in breast care, and provide physicians and patients with educational resources that guide their journey. Our drive for innovation is rivaled only by our compassion for the people we serve, from the clinicians and surgeons who demand consistently precise solutions, to the women and families seeking peace of mind.
As the pioneers in vacuum-assisted breast biopsy, Mammotome is proud to celebrate over 25 years of innovation. More than 10 million women worldwide have had a procedure using a minimally invasive Mammotome breast biopsy system. An operating company of Danaher Corporation since 2014, the Mammotome brand is sold in over 45 different countries throughout the world.
Mammotome is the global leader in breast biopsy markers, offering clinicians customized solutions for every breast biopsy need.